Biogen Idec says a candidate nominated by activist shareholder Carl Icahn won a seat on the drug maker's board of directors as part of a contentious proxy fight, but the votes are still too close to call on a second seat.Icahn claims his portfolio manager Dr. Alexander J. Denner and Dr. Richard C. Mulligan, a Harvard Medical School professor, have won seats on the board.
Biogen Idec says Icahn candidate wins board seat